Constellation Brands (NYSE:STZ) reported quarterly earnings of $3.17 per share which beat the analyst consensus estimate of $2.81 by 12.81 percent. This is a 33.19 percent increase over earnings of $2.38 per share from the same period last year. The company reported quarterly sales of $2.65 billion which beat the analyst consensus estimate of $2.51 billion by 5.78 percent. This is a 11.98 percent increase over sales of $2.37 billion the same period last year.
Rhythm Pharmaceuticals Acquires Xinvento, A Netherlands-based Biotech Company Focused On Developing Therapies For Congenital Hyperinsulinism For $5M Upfront
According to the terms of the acquisition agreement, Rhythm B.V. will purchase 100 percent of Xinvento’s fully-diluted equity for an upfront payment of $5 million (subject to customary adjustments) with an
